Purpose: This study systematically compared the images from readout-segmented echo-planar diffusion-weighted imaging (RESOLVE-DWI [RS-DWI]) and simultaneous multislice accelerated RESOLVE-DWI (SMS-RS-DWI) in patients with nasopharyngeal carcinoma (NPC) in qualitative and quantitative aspects.

Method: Forty-four patients with NPC were included. The RS-DWI and prototypic SMS-RS-DWI sequences were performed on all patients. Images were qualitatively evaluated by 4 independent radiologists using a 5-point Likert scale. For quantitative evaluation, the maximum and minimum diameters and the maximum tumor areas were determined for both DWI sequences and compared with the T2-weighted imaging (T2WI) to evaluate image distortions. The apparent diffusion coefficient was measured in the slice with the maximum tumor profile.

Results: The SMS-RS-DWI was superior to RS-DWI with respect to overall image quality (3.40 ± 0.53 vs 2.71 ± 0.48, P < 0.0001) and tumor edge sharpness (3.29 ± 0.65 vs 2.64 ± 0.47, P < 0.0001). Susceptibility artifacts were significantly less severe in SMS-RS-DWI than in RS-DWI (0.85 ± 0.57 vs 1.36 ± 0.57, P < 0.0001). There was no significant overestimation or underestimation of the tumor geometry using the SMS-RS-DWI or RS-DWI compared with T2WI. The quantitative analysis showed a slightly higher agreement for SMS-RS-DWI with T2WI than RS-DWI for maximum diameter, minimum diameter, and maximum tumor area. The apparent diffusion coefficient values showed no significant differences between the 2 DWI techniques ( P > 0.05).

Conclusions: At 3 T, SMS-RS-DWI is a useful technique for diagnosing NPC. It substantially improves different aspects of image quality by providing higher spatial resolution and fewer susceptibility artifacts with more extensive anatomic coverage compared with RS-DWI.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477861PMC
http://dx.doi.org/10.1097/RCT.0000000000001327DOI Listing

Publication Analysis

Top Keywords

maximum tumor
12
nasopharyngeal carcinoma
8
simultaneous multislice
8
apparent diffusion
8
diffusion coefficient
8
image quality
8
susceptibility artifacts
8
sms-rs-dwi rs-dwi
8
sms-rs-dwi
7
rs-dwi
6

Similar Publications

The emergence of self-propelling magnetic nanobots represents a significant advancement in the field of drug delivery. These magneto-nanobots offer precise control over drug targeting and possess the capability to navigate deep into tumor tissues, thereby addressing multiple challenges associated with conventional cancer therapies. Here, Fe-GSH-Protein-Dox, a novel self-propelling magnetic nanobot conjugated with a biocompatible protein surface and loaded with doxorubicin for the treatment of triple-negative breast cancer (TNBC), is reported.

View Article and Find Full Text PDF

This study aimed to investigate the correlation between baseline MRI features and baseline carcinoembryonic antigen (CEA) expression status in rectal cancer patients. A training cohort of 168 rectal cancer patients from Center 1 and an external validation cohort of 75 rectal cancer patients from Center 2 were collected. A nomogram was constructed based on the training cohort and validated using the external validation cohort to predict high baseline CEA expression in rectal cancer patients.

View Article and Find Full Text PDF

I-mIBG THERAPY IN RELAPSED/REFRACTORY NEUROBLASTOMA: A WEAPON FROM THE FUTURE PAST.

Crit Rev Oncol Hematol

December 2024

Nuclear Medicine Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy; Department of Life Sciences and Public Health, Catholic University of the Sacred Heart, Rome, Italy.

Neuroblastoma (NB) is the most common extracranial solid tumor in children, with variable outcomes ranging from spontaneous remission to high-risk cases often leading to relapse or refractory disease. Approximately 50% of patients with NB have high-risk features, often experiencing relapse or refractory disease despite intensive treatments and the prognosis remains poor, with long-term event-free survival (EFS) rates below 10%,Radioactive iodine-labeled meta-iodobenzylguanidine (¹³¹I-mIBG) therapy, leveraging NB cells' radiosensitivity and expression of the norepinephrine transporter (NET), has shown promise in treating relapsed or refractory NB. Since 1985, ¹³¹I-mIBG has been studied to determine the maximum tolerated dose and side effects, with recent trials exploring its use in front-line treatment.

View Article and Find Full Text PDF

Oncolytic therapy, inducing cell death via cell membrane lysis, holds considerable promise in cancer treatment. However, achieving precise control over the structure and function of oncolytic materials for highly selective oncolytic therapy is a key challenge in the context of the subtle differences between tumor and normal tissues/cells. Herein, we report the development of pH-ultrasensitive oncolytic polyesters (pOPs) with an alternating sequence of ionizable and hydrophobic groups.

View Article and Find Full Text PDF

Radiotherapy resistance is one of the main reasons for the dismal clinical outcome of patients with esophageal squamous cell carcinoma (ESCC). Therefore, clarifying the targets and molecular mechanisms of radiotherapy resistance in ESCC is of great theoretical and clinical significance to enhance the efficacy of radiotherapy. In this study, GPR37 was identified as a key factor facilitating ESCC radiosensitization.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!